"Lavoriamo ogni giorno insieme per vincere il cancro: il CRO è un Istituto di Ricovero e Cura a Carattere Scientifico specializzato nella cura e nella ricerca sui tumori in tutte le loro fasi: prevenzione, diagnosi, trattamento e riabilitazione. L’offerta clinica del Centro di Riferimento Oncologico comprende trattamenti di oncologia medica innovativi, chirurgia generale, senologica e ginecologica, e un’avanzata radioterapia sia curativa che palliativa. Una specifica Area Giovani è dedicata agli adolescenti con tumori. La ricerca, per lo più clinica e traslazionale, copre soprattutto la genetica e la biologia dei tumori, l’epidemiologia, le neoplasie emolinfopoietiche, i tumori solidi, i tumori associati ad agenti infettivi."

During the past decade, Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari" are "Chronic Lymphoid Leukemia" (1 trials), "Hematologic Malignancies" (1 trials) and "Large-B-cell Diffuse Lymphoma" (1 trials). Many other conditions were trialed in "Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari" in a lesser frequency.

Most popular intervention types in "Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy" (1 trials), "Quality of life assessment" (1 trials), "Rituximab" (1 trials) and "Tenofovir alafenamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".